NMN-based nutritional formulations
NMN-based nutritional formulations has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Oct 23, 2026: “Unlocking the Healthy Aging Potential of Novel NMN-Based Nutritional Formulations: Cardiopulmonary, Cognitive, and Aging-Related Outcomes in a 42-Day Open-Label Study”.
1 paper studies it1 findingUpdated
1 new paper in 30 daysSee all 1
“In the separate uncontrolled molecular pilot, DNAm PhenoAge relative to chronological age decreased by approximately 4.1 years, accompanied by nominal transcriptomic changes.”
- 1 lab in 1 country
- Funder: Abe Yoando Pharma
- Human trial1
What is NMN-based nutritional formulations linked with?
1Studies link NMN-based nutritional formulations with 1 measure, most often DNAm PhenoAge relative to chronological age (1 study).
DNAm PhenoAge relative to chronological age
downin humans1
1 study
DNAm PhenoAge relative to chronological age
downin humans1
NMN-based nutritional formulations are associated with DNAm PhenoAge relative to chronological age in humans (Separate uncontrolled molecular pilot) (Approximately −4.1 years).
“In the separate uncontrolled molecular pilot, DNAm PhenoAge relative to chronological age decreased by approximately 4.1 years, accompanied by nominal transcriptomic changes.”
Human trialSeparate uncontrolled molecular pilotn = 8
Nutrients